SCHEMBL7991788

SCHEMBL7991788

Cc1cccc(Cn2cnc3nc(-c4ccccn4)nc(O)c32)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.46
CYP11B2 P19099 3/20 0.46
ALDH1A1 P00352 3/20 0.46
HIF1A Q16665 1/20 0.41
GRM5 P41594 2/20 0.40
F2 P00734 1/20 0.40
F12 P00748 1/20 0.40
HPGD P15428 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
LMNA P02545 5/20 0.39
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TSHR P16473 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
MAPT P10636 1/20 0.38
ADORA2A P29274 1/20 0.37
PKM P14618 1/20 0.37
GAA P10253 1/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991532 0.88 SMN1; SMN2 (0.43) CYP11B1CYP11B2ALDH1A1HIF1AHPGD
SCHEMBL7985492 0.88 SMN1; SMN2 (0.42) ALDH1A1HIF1AF2F12HPGD
SCHEMBL7992177 0.87 SMN1; SMN2 (0.42) CYP11B1CYP11B2HIF1AGRM5LMNA
SCHEMBL7974007 0.87 KDM4C (0.41) CYP11B1CYP11B2ALDH1A1GRM5LMNA
SCHEMBL7985456 0.87 GAA (0.48) ALDH1A1HIF1AGRM5SMN1; SMN2MAPT
SCHEMBL7974268 0.86 CYP11B1 (0.48) CYP11B1CYP11B2ALDH1A1HPGDNPSR1
SCHEMBL7974309 0.84 CYP11B1 (0.45) CYP11B1CYP11B2ALDH1A1HPGDLMNA
SCHEMBL7988747 0.84 CYP11B1 (0.44) CYP11B1CYP11B2ALDH1A1HPGDLMNA
SCHEMBL7985236 0.82 LMNA (0.44) CYP11B1CYP11B2ALDH1A1HPGDLMNA
SCHEMBL7974247 0.82 CYP11B1 (0.44) CYP11B1CYP11B2ALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed